NeuroGen Pharma announced a strategic licensing agreement with Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), securing...
Eli Lilly and Company (NYSE: LLY) has agreed to acquire Kelonia Therapeutics, a clinical-stage biotechnology...
WeiMai Inc., an artificial intelligence–driven disease management company based in Hangzhou, has filed its initial...
Biogen Inc. (NASDAQ: BIIB) has finalized an agreement with TJ Biopharma, a China-based biopharmaceutical company,...
UCB (EBR: UCB) has agreed to acquire Neurona Therapeutics, a U.S.-based biotechnology company developing NRTX-1001,...
Pulnovo Medical, a Chinese pulmonary hypertension (PH) has secured over USD 100 million in an...
SenseTime, a leading Chinese smart diagnosis and treatment solution provider, has completed its Series A...
Mabwell (Shanghai) Bioscience Co., Ltd. (SHA: 688062, HKG: 2493) successfully completed its initial public offering...
Eli Lilly & Co. (NYSE: LLY) is reportedly engaged in advanced negotiations to acquire Kelonia...
AbbVie Inc. (NYSE: ABBV), the US pharmaceutical giant, has announced a strategic partnership with the...
Annoroad Gene Technology (Beijing) Co., Ltd., a leading Chinese provider of integrated life science sequencing...
Mabwell (Shanghai) Bioscience Co., Ltd. (SHA: 688062) has announced a new licensing agreement with a...
Tigermed Consulting Co., Ltd. (SHE: 300347), a leading Chinese Contract Research Organization (CRO), has announced...
Amoytop Biotech Co., Ltd. (SHA: 688278), a leading Chinese biopharmaceutical company, has entered into a...
Yifan Pharmaceutical Co., Ltd. (SHE: 002019), a leading Chinese biopharmaceutical company, has announced a new...
GE HealthCare Technologies Inc. (NASDAQ: GEHC), a global leader in medical technology and life sciences,...
Betta Pharmaceuticals Co., Ltd. (SHE: 300558), a China-based oncology-focused biopharma company, has entered into a...
Kailera Therapeutics, Inc. (NASDAQ: KLRA), a US-based biotech venture established in 2024 by China’s Jiangsu...
Annoroad Gene Technology (Beijing) Co., Ltd. has filed a prospectus with the Hong Kong Stock...
Ty Biotech (HKG: 1332) has announced a strategic cooperation agreement with Shenzhen University to commercialize...